499 results on '"Chamaillard, Mathias"'
Search Results
2. Use of 2,6-diaminopurine as a potent suppressor of UGA premature stop codons in cystic fibrosis
3. Oral supplementation with selected Lactobacillus acidophilus triggers IL-17-dependent innate defense response, activation of innate lymphoid cells type 3 and improves colitis
4. The colibactin-producing Escherichia coli alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistance
5. The biotherapeutic Clostridium butyricum MIYAIRI 588 strain potentiates enterotropism of Rorγt + Treg and PD-1 blockade efficacy
6. NOD2 Influences Trajectories of Intestinal Microbiota Recovery After Antibiotic Perturbation
7. NLRP12 interacts with NLRP3 to block the activation of the human NLRP3 inflammasome
8. NLRP6 controls pulmonary inflammation from cigarette smoke in a gut microbiota-dependent manner
9. Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer
10. Parvimonas micra , an oral pathobiont associated with colorectal cancer, epigenetically reprograms human colonocytes
11. Loss of NOD2 in macrophages improves colitis and tumorigenesis in a lysozyme-dependent manner
12. Activation of Nod2 signaling upon norovirus infection enhances antiviral immunity and susceptibility to colitis
13. MAVS deficiency induces gut dysbiotic microbiota conferring a proallergic phenotype
14. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
15. NOD2 in monocytes negatively regulates macrophage development through TNFalpha
16. Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease.
17. Gene-Environment Interaction Modulated by Allelic Heterogeneity in Inflammatory Diseases
18. The battlefield in the war against attaching-and-effacing bacterial pathogens: Monocytes, macrophages and dendritic cells in action
19. Microbiote intestinal : qu’en attendre au plan physiologique et thérapeutique ?
20. The human gut microbiome as source of innovation for health: Which physiological and therapeutic outcomes could we expect?
21. Lactobacillus reuteri 5454 and Bifidobacterium animalis ssp. lactis 5764 improve colitis while differentially impacting dendritic cells maturation and antimicrobial responses
22. The biotherapeutic Clostridium butyricum MIYAIRI 588 strain potentiates enterotropism of Rorγt+ Treg and PD-1 blockade efficacy.
23. Activation of Nod2 signalling upon Norovirus infection enhances antiviral immunity and susceptibility to colitis
24. Spatially-resolved metabolomic identifies colibactin-specific principles of reprogrammed lipid metabolism to promote cancer progression
25. Tirap controls Mycobacterium tuberculosis phagosomal acidification
26. Characterisation of gut microbiota composition in patients with axial spondyloarthritis and its modulation by TNF inhibitor treatment
27. Short- and Long-term Repercussions of Vancomycin on Immune Surveillance and the Efficacy of Antitumor Treatments
28. Microbe-mediated intestinal NOD2 stimulation improves linear growth of undernourished infant mice
29. Use of 2,6-diaminopurine as a potent suppressor of UGA premature stop codons in cystic fibrosis
30. NOD2 gene variant is a risk factor for postoperative complications in patients with Crohn's disease: A genetic association study
31. CARD8 gene variant is a risk factor for recurrent surgery in patients with Crohn's disease
32. The NLRP6 protein is very faintly expressed in several normal and cancerous epithelial cells and may be confused with an unrelated protein
33. Proteasomal degradation of NOD2 by NLRP12 in monocytes promotes bacterial tolerance and colonization by enteropathogens
34. The extracellular matrix controls stem cell specification and crypt morphology in the developing and adult mouse gut
35. IL17 and/or IL22 as Potential Target(s) for Crohn’s Disease
36. Monocyte intrinsic NOD2 signalling inhibits pathogenic macrophage differentiation and its loss in inflammatory macrophages improves intestinal inflammation
37. Harnessing the Vnn1 pantetheinase pathway boosts short chain fatty acids production and mucosal protection in colitis
38. NOD-like receptors in asthma
39. A Protective Role of NOD2 on Oxazolone-induced Intestinal Inflammation Through IL-1β-mediated Signalling Pathway
40. IL-17/23, potential targets for Crohn’s disease
41. NLRs: a Cytosolic Armory of Microbial Sensors Linked to Human Diseases
42. Harnessing the Vnn1 pantetheinase pathway boosts short chain fatty acids production and mucosal protection in colitis.
43. Nod2-mediated recognition of the microbiota is critical for mucosal adjuvant activity of cholera toxin
44. Enterocyte loss of polarity and gut wound healing rely upon the F-actin—severing function of villin
45. Hemidesmosome integrity protects the colon against colitis and colorectal cancer
46. Effects of enteral polymeric diet on gut microbiota in children with Crohnʼs disease
47. Diurnal Interplay between Epithelium Physiology and Gut Microbiota as a Metronome for Orchestrating Immune and Metabolic Homeostasis
48. Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury
49. Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon
50. Virulent Bacteria as Inflammatory and Immune Co-Factor in Colon Carcinogenesis: Evidence From Two Monozygotic Patients and Validation in CRC Patient and Healthy Cohorts
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.